USRM Chief Science Officer Featured in Live Interview for Biohacker Summit in Helsinki
MIAMI, FL – May 3, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announced…
Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales
SUNRISE, FL – April 24, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced…
USRM Announces 2017 Financial Results
SUNRISE, FL – April 16, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…
Newest Clinic Opens Today at The Villages in Central Florida
SUNRISE, FL – April 9, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced…
USRM Chief Science Officer to Present at Paleo f(x) Ancestral Healing Conference in Austin, Texas
SUNRISE, FL – March 20, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, is…
USRM Chief Science Officer to Present at Academy of Regenerative Practices Conference
SUNRISE, FL – February 28, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announces…
USRM Posts Live Webinar with World Renowned Biohacker
‘Enhancing Sexual Performance with Stem Cell Therapy’ Available for Playback SUNRISE, FL – Feb. 20, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary,…
CEO Blog: February 2018
Dear Shareholders and Friends, Thank you all so much for taking the time to learn more about our recent progress. In this post, we want to take a moment to…
USRM CSO to Host Live Stem Cell Info Webinar with World Renowned Biohacker
‘Discussing Enhancing Sexual Performance with Stem Cell Therapy’ Feb. 17 at Noon SUNRISE, FL – Feb. 14, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development…
USRM Successfully Launches Stem Cell Webinar Series
Open to Global Participation, More than 100 Attendees in First Q & A SUNRISE, FL – Feb. 12, 2018 – Dr. Kristin Comella, Chief Science Officer of U.S. Stem Cell,…
USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
Failure of Opioids & Economic Growth Driving Force, CSO to Host Live Info Webinar SUNRISE, FL – Feb. 6, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in…
USRM Chief Science Officer Featured in Powerful Stem Cell Docuseries
SUNRISE, FL – Jan. 24, 2018 – U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today…